Trials / Completed
CompletedNCT01210638
Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalence Study of Oxymorphone Hydrochloride IR 10 mg Tablets, With a Naltrexone Block, Under Fasted Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to prove the bioequivalence of Oxymorphone Hydrochloride 10 mg Tablets under fasting conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxymorphone | 10 mg tablet |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2010-09-28
- Last updated
- 2018-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01210638. Inclusion in this directory is not an endorsement.